We have previously found that carboxymethylpullulan (CMPul) conjugated with sialyl Lewis X (Neu5Aca a2-3Galb b1-4(Fuca a1-3)GlcNAc-, 2-3SLe x ) preferentially accumulates in the lymph nodes and spleen. In the present study, we investigated the structural requirements of the 2-3SLe
Leukocytes adhere to vascular endothelial cells in response to infection, physical injury or exposure to allergen and then migrate between endothelial cells into underlying tissues. Recently, the trafficking mechanism of leukocytes is being revealed at the molecular level. Cell adhesion molecules such as selectins and integrins, 1) have been found to play essential roles in recruiting leukocytes from the blood.
We chose E-selectin as a target for delivering a drug to inflammatory sites, because it is specifically expressed on vascular endothelial cells stimulated by cytokines such as IL-1b or TNF-a at the inflammatory sites 1) and recognizes small sialylated, fucosylated oligosaccharides such as sialyl Lewis X (Neu5Aca2-3Galb1-4(Fuca1-3)GlcNAc-, 2-3SLe x ) and sialyl Lewis A (Neu5Aca2-3Galb1-3(Fuca1-4)GlcNAc-, SLe a ) in a calcium-dependent manner. 2) We conjugated SLe x , which is susceptible to urinary excretion, with the polysaccharide carboxymethylpullulan (CMPul) to improve the disposition characteristics of 2-3SLe
x . 3) This conjugate had E-selectin binding activity and a prolonged circulating time due to the presence of the 2-3SLe
x moiety and CMPul, respectively. 3, 4) In the tissue distribution experiments, 2-3SLe
x -CMPul conjugates accumulated 300-fold more in the inflammatory site than 2-3SLe
x and were verified to be effective for use in the inflammatory lesion-specific drug targeting. 3) On the other hand, in these studies, we unexpectedly found that a significant amount of 2-3SLe x -CMPul was sequestered by the spleen but not CMPul, Neu5Ac-and SLN-CMPul. 5 ) Diethylaminoethyldextran 6) and dextran grafted onto poly-L-lysine 7) have already been reported to be preferentially taken up by the spleen and lymph nodes, but their amount in the spleen were much less than that of x -CMPul. Also, microspheres coated with polyoxyethylene/polyoxypropylene block copolymer poloxamine-908 8) and liposomes modified with ganglioside GM1 9, 10) have shown enhanced accumulation in the spleen. Their accumulation depended on their size (approximately Ͼ200 nm) and was followed by a significant change of the liver concentration, differing from the disposition characteristics of 2-3SLe x -CMPul. Taking advantage of these characteristics, the development of a spleen-targeting device would have important implications for the treatment of autoimmune diseases and Hodgkin's disease, for the elicitation of the antigen-specific immune responses and for imaging of the spleen during conditions such as polysplenia, multiple trauma and infractions of the spleen. We therefore tried to estimate the influence of 2-3SLe
x moiety on the disposition characteristics of CMPul.
In the present study, we investigated the disposition characteristics of oligosaccharide-CMPul conjugates including 2-3SLe
x -CMPul to the peripheral lymphoid tissues in rats. In order to examine their microdistribution at the cellular level, we carried out microautoradiography analyses.
MATERIALS AND METHODS

Syntheses of Oligosaccharides and OligosaccharideCMPul Conjugates
CMPul (degrees of substitution (d.s.) of the carboxymethyl group: 0.6) was prepared by Nogusa's method 4) from pullulan (apparent M.W. 150000), which was purchased from Hayashibara Biochemical Laboratories, Inc. (Okayama, Japan). Oligosaccharides and their conjugates with CMPul were synthesized as described previously.
11) 2-3SLe
x , a2-6-linked sialic acid (Neu5Aca2-6Galb1-4(Fuca1-3)GlcNAc-, 2-6SLe x ) and Neu5Aca2-3Galb1-4GlcNAc-, sialyl N-acethyllactosamine (SLN) were synthesized by an improved method. These oligosaccharides were introduced to CMPul through hexaethyleneglycol as a spacer. The d.s. refers to the number of modified substances, such as carboxymethyl group, SLe x , and SLN, per glucose residue in the pullulan molecule.
These oligosaccharide-CMPul conjugates were labeled with 3 H for the tissue distribution experiments as described previously.
3)
Tissue Distribution Experiments in Rats Female Lewis rats (150-170 g body weight: age 7 weeks) were obtained from Charles River Japan, Inc. and allowed free access to water and food (standard laboratory chow). Rats were anesthetized with diethyl ether.
3 H-labeled CMPul or oligosaccharide-CMPul conjugates were administered intravenously at a dose of 1 mg/kg. Samples of blood were collected throughout the 24-h experiment period. The rats were anesthetized again and exsanguinated through the vena cava at 24 h after intravenous administration. The lung, spleen, kidney, liver, mesenteric and cervical lymph node were then excised, rinsed with saline and weighed. Samples of blood, plasma and tissues were decolorized with 0.4 ml of 2-propanol and 0.2 ml hydrogen peroxide, and then dissolved in 1. Microautoradiography Female Lewis rats (150-170 g body weight: age 7 weeks) were used for microautoradiography analyses at the cellular level. After anesthesia with diethyl ether, 3 H-labeled CMPul or oligosaccharide-CMPul conjugates, with specific activities of approximately 3 mCi/0.5 mg/ml were administered intravenously at a dose of 2 ml/kg to rats. The rats were anesthetized again and exsanguinated through the veva cava at 2 h or 24 h after intravenous administration. The spleen, liver, mesenteric and cervical lymph node were then excised and rinsed with saline. The spleen and liver were sliced into 3-mm cubes. These cubes, the lymph nodes and bone marrow were fixed overnight in fixative solution (2.0% paraformaldehyde, 0.5% glutaraldehyde, 0.1 M phosphate buffer (pH 7.2)) at room temperature. After fixation, they were rinsed with 0.1 M phosphate buffer (pH 7.2) containing 7% sucrose, dehydrated with ethanol series and embedded in Technovit 7100 (Kulzer & Co GmbH, Wehrheim/Ts. Germany). To permit high-resolution localization of the labeled compounds under light microscopy, tissue blocks were sectioned into 1.5-mm slices and mounted on glass slides which were then dipped in Kodak NTB-3 emulsion and exposed at 4°C for 2 weeks. After exposure, the slides were developed in Kodak Dektol and then counterstained with a mixture of methylene blue and basic fuchsin.
RESULTS
Uptake of 2-3SLe
x -CMPul by the Spleen and Lymph Nodes Table 1 shows the structures and physicochemical characteristics of CMPul conjugates. As the d.s. of the added saccharides was nearly constant, the molecular weight and size of these conjugates were similar. In order to investigate the ability of 2-3SLe
x -CMPul to target the inflammatory site, we previously estimated the tissue distributions of intravenously administered 2-3SLe
x -(d.s.ϭ0.13), SLN-, Neu5Ac-CMPul and non-modified CMPul using mice with the ear edema model induced by arachidonic acid.
3) We unexpectedly found that a significant amount of 2-3SLe x -CMPul accumulated in the marginal zone of the spleen as well as in the inflamed ear. 5) We tried to verify whether this accumulation of 2-3SLe x -CMPul in the spleen was dependent on the number (d.s.) of 2-3SLe
x moieties on CMPul and the carbohydrate structure of 2-3SLe
x . First, we examined the tissue distribution of 2-3SLe
x -CMPul, which had various numbers of 2-3SLe x moieties in CMPul, in rats. When the d.s. of the 2-3SLe
x moiety was 0.05, the concentration-time profile in plasma was identical to that of 2-3SLe x -CMPul (d.s.ϭ0.13) (Fig. 1a) , although the accumulation in the spleen was a little lower than that of 2-3SLe x -CMPul (d.s.ϭ0.13) (Fig. 1b) . We also found that 2-3SLe
x -CMPul (d.s.ϭ0.13) accumulated not only in the spleen (66.3% of dose/g) but also in the mesenteric (127.8% of dose/g) and cervical (22.2% of dose/g) lymph nodes (Fig.  1b) . On the other hand, when the d.s. of the 2-3SLe
x moiety decreased to 0.025, the concentrations in the spleen and the mesenteric and cervical lymph nodes drastically decreased and were similar to those of CMPul (Fig. 1b) . These results indicated that this accumulation of 2-3SLe x -CMPul in the peripheral lymphoid tissues was dependent on the number of 2-3SLe
x moieties. Next, we tried to determine the carbohydrate structure necessary for the accumulation in the spleen and lymph nodes. Because the non-reducing sugar would participate in the sugar-protein binding in general, we modified the sialic acid and fucose residues. Elimination of fucose from 2-3SLe
x resulted in a significantly prolonged circulation time and low concentrations in the spleen (13.6% of dose/g) and the mesenteric (49.0% of dose/g) and cervical (14.4% of dose/g) lymph nodes (see SLN-CMPul in Fig. 2 ). Furthermore, in order to change the position of sialic acid, it was linked to the 6-hydroxyl group of galactose (2-6SLe x ), which is an isomer of 2-3SLe
x . This modification also caused high plasma concentration and low uptakes by the spleen (16.4% of dose/g) 1276 Vol. 27, No. 8 a) Degree of substitution. The d.s. refers to the ratio of glucose residues, which were modified with mono-or oligosaccharides, to total glucose residues in the pullulan molecule. b) The content of added saccharide was quantified by resorsinol method. c) The apparent molecular weight of CMPul was estimated by gel filtration. and the mesenteric (55.2% of dose/g) and cervical (13.3% of dose/g) lymph nodes (see x -CMPul in Fig. 2 ). These results suggested that the accumulation of 2-3SLe
x -CMPul in the peripheral lymphoid tissues may also be markedly affected by the carbohydrate structure of the 2-3SLe
x moiety. Microdistributions of CMPul Conjugates Microautoradiography analyses using mice with ear edema have revealed the presence of a large amount of 2-3SLe x -CMPul in the marginal zone of the spleen.
5) However, we could not clarify what kind of cells are responsible for this accumulation. Here, we investigated the microdistributions of CMPul conjugates in the spleen and lymph nodes at the cellular level using fixed rat tissues. Table 2 summarizes the cells or parts of tissues where 3 H-labeled CMPul, 2-3SLe x -and SLNCMPul were located and the extent of their amount. All conjugates were located in similar parts of the spleen and lymph nodes. As far as CMPul and 2-3SLe x -CMPul are observed in a high magnification of a microscope, there is no difference between the number of silver grains derived from them (Table 2) . However, the observation in a low magnification make the difference clear, correlating well with the amount of radioactivity in the tissue distribution experiments. In the lymph nodes, most of the silver grains were observed in the medullary sinus macrophages ( Table 2, Figs. 3a, c) and also the smaller part in the marginal sinus macrophages, whereas there were few silver grains in the tingible macrophages and in the vicinity of the post-capillary venules, which are called high endothelial venules (Table 2 ). In the spleen, most of the silver grains were ingested by macrophages in the marginal zone, but there were few grains in the white and red pulp ( Table 2, Figs. 3b, d ). There was no grain in the bone marrow and the liver.
In order to define an influx route into the lymph nodes, microautoradiograms of CMPul conjugates 2 h after intravenous administration were examined. This was the earliest time that we could find differences among CMPul conjugates in tissue distribution experiments. 5) However, CMPul conjugates were taken up by medullary sinus macrophages and a few or few silver grains were found in the marginal sinus of the lymph nodes and the vicinity of the high endothelial venules, where the influx site of lymph and the infiltration site of lymphocytes are located, respectively (Table 2 ). This result was almost the same as that 24 h after intravenous administration except that smaller amounts were observed.
DISCUSSION
In this study, we demonstrated that a significant amount of CMPul, which was designed to avoid uptake by the liver, was observed in the spleen and mesenteric and cervical lymph 1278 Vol. 27, No. 8 
ϩϩ, a large amount of silver grains; ϩ, a considerable silver grains; Ϯ, few silver grains; Ϫ, very few silver grains, or none at all. nodes after intravenous administration. Interestingly, in the case of CMPul conjugated with 2-3SLe x , about a 2-fold higher concentration in these tissues was observed. This additive effect suggests that 2-3SLe
x could improve the disposition characteristics of CMPul for targeting to these peripheral lymphoid tissues. In order to verify whether this accumulation of 2-3SLe x -CMPul in the spleen and lymph nodes would occur in a 2-3SLe
x -dependent manner, we examined both the number (d.s.) of 2-3SLe
x moieties on CMPul and the carbohydrate structure necessary for the accumulation. With regard to the d.s. of the 2-3SLe
x moiety, the uptake of 2-3SLe
x -CMPul by the spleen and the lymph nodes decreased as the number of 2-3SLe
x moieties decreased and the amount of 2-3SLe
x -CMPul was finally similar to that of CMPul when the d.s. of 2-3SLe
x moiety was 0.025 ( Fig. 1) . Thus the accumulation of 2-3SLe x -CMPul in the spleen and lymph nodes was dependent on the number of 2-3SLe
x moieties in the CMPul backbone and the d.s. of 2-3SLe
x moiety needed to be more than 0.05. With respect to the carbohydrate structure, eliminating the fucose residue (SLN) and changing the a2-3-to a2-6-linked sialic acid residue (2-6SLe
x ) also caused a significant decrease in the amount of 2-3SLe
x -CMPul in these tissues (Fig. 2) . Because these modifications do not largely affect the physicochemical characteristics of conjugates such as molecular weight and negative charges, the decrease would be due to structural changes of the 2-3SLe
x moiety. It is also noteworthy that the amount of 2-3SLe
x -CMPul in both the spleen and the lymph nodes varied with a similar pattern.
The question arises of what in the peripheral lymphoid tissues attracted 2-3SLe x -CMPul. The first possibility is that selectins led to this accumulation because the 2-3SLe
x moiety in 2-3SLe x -CMPul was recognized by E-selectin 3) and the fucose and 2-3 linked sialic acid that are essential sugar residues for binding to selectins were structurally required for the accumulation in the peripheral lymphoid tissues. 2) However, E-and P-selectins are not thought to be constitutively expressed in normal spleen and lymph nodes.
12) Although L-selectin is constitutively expressed on various kinds of leukocytes 1) and may transport 2-3SLe
x -CMPul to the peripheral lymphoid tissues, the ratio of the blood concentration to the plasma concentrations of 2-3SLe x -CMPul was similar to that of other CMPul conjugates (Figs. 1, 2) , indicating that 2-3SLe x -CMPul does not preferentially bind to blood cells.
Another possibility is that an unknown molecule with similar binding properties to selectins is expressed in the peripheral lymphoid tissue. One candidate might be a macrophage receptor with a collagenous structure (referred to as MARCO) expressed in a subset of macrophages in the marginal zone of the spleen and the medullary region of lymph nodes, 13) which are identical to the cells that took up abundant amount of 2-3SLe x -CMPul (Table 2) . Because the spleen is a part of the reticulo-endothelial system (RES), we first thought that its uptake of 2-3SLe x -CMPul might result from the non-specific exclusion of foreign substances by the RES. However, in the tissue distribution experiments, 2-3SLe
x -CMPul preferentially accumulated in the spleen and lymph nodes rather than in the liver. The decrease of the concentration in the spleen and lymph nodes on modification of the 2-3SLe
x moiety was not accompanied by an elevation of the liver concentration, which remained low (Ͻ0.6% of dose/g) (Figs. 1, 2) . These results suggested that the mechanism by which 2-3SLe x -CMPul is taken up in the peripheral lymphoid tissues may differ from that in the liver. Since MARCO exists only in the spleen and lymph nodes, and not in the liver, this may explain the disposition characteristics of 2-3SLe
x -CMPul. 13) MARCO was shown to bind Gram-positive and negative bacteria, and acetylated LDL, but a specific ligand is still unclear. 13) Another possible candidate might be sialic acid-binding immunoglobulin superfamily lectins (referred to as siglecs). Eleven members have been identified in the human genome including sialoadhesin (Siglec-1), CD22 (Siglec-2), CD33 (Siglec-3), myelin-associated glycoprotein (MAG; Siglec-4), and Siglecs-5-11 which are closely related to CD33. [14] [15] [16] [17] In the murine genome, eight siglec genes have been identified comprising orthologs for sialoadhesin, CD22, CD33, MAG, and Siglec-10 (designated mSiglec-G), and three other CD33 related siglecs (Siglec-E, -F, and -H) that have no-clear-cut human ortholog. 16) In our case, sialoadhesin could be the most suitable candidate. Namely, sialoadhesin is expressed at high levels on macrophages in the marginal zone 18) and binds to 2-3SLe x moiety. 19) On the other hand, the fact that sialoadhesin recognize SLN moiety as at the same level of affinity as 2-3SLe
x moiety is not compatible with our results. 19) In order to clarify which molecule is responsible for the accumulation of 2-3SLe x -CMPul in the peripheral lymphoid tissue, further in vivo study using specific molecule knock-out mice will be necessary.
Microautoradiography has shown that CMPul, 2-3SLe xCMPul and SLN-CMPul were located in almost the same parts of the spleen and lymph nodes (Fig. 3, Table 2) . At the cellular level, they were found to be ingested by the medullary sinus and the marginal sinus macrophages in the lymph nodes and the macrophages in the marginal zone of spleen (Table 2 ). In the spleen, there are several types of macrophages, which include marginal zone macrophages, marginal metallophilic macrophages and red pulp macrophages. The former two are thought to have the special role of presenting thymus-independent type 2 (TI-2) antigens 20) to the marginal zone type B cells, whereas the latter functions as a major scavenger. 21 ) Therefore, we thought that 2-3SLe x -CMPul, which was incorporated by the macrophages in the marginal zone of spleen, would not be recognized as a simple foreign substance, a target for phagocytosis, but as a TI-2 antigen or some other substance in the rat spleen. In fact, 2-3SLe
x -CMPul has some typical properties of TI-2 antigens, namely large molecular weight, repeating antigenic epitopes and resistance to degradation in vivo. 20) Many drug carrier particles, even modified with ganglioside GM1, 9, 10) poly(ethylene glycol) 9) or block co-polymer polyoxyethylene/polyoxypropylene poloxamine-908 22) to evade the RES to some extent, are filtered out from the blood at the spleen and ingested by scavengers. For example, Moghimi and colleagues 22) have demonstrated that poloxamine-908 coated microspheres were phagocytosed by red pulp macrophages after being filtered by the interendothelial slit in the sinusoidal spleen that seldom exceeds 0.2-0.5 mm in width. 23) On the other hand, CMPul conjugates would not be filtered out by the spleen, because of their small molecular size (at least Ͻ10 nm), which could not be measured quanti-tatively by quasielastic light scattering studies, and would be sequestered by macrophages in the marginal zone. Because the white pulp and the marginal zone in the spleen are the major sites of immune responses, 24) whereas the red pulp macrophages are immunosuppressive, 25) CMPul conjugates are preferable to the filtered particles to elicit an immune response in the sinusoidal spleen. Other work has shown that Ficoll, 21) neutral polysaccharide, and immune-stimulating complexes (iscom), 26) a vaccine with built-in adjuvant properties, can induce humoral immunity 26, 27) because they are preferentially taken up by marginal metallophilic macrophages at the border of the marginal zone and close to the periarteriolar lymphocyte sheath (PALS) in the spleen after coadministration with antigen. Iscom is able to elicit even cellmediated immunity. 26) These observations demonstrated that CMPul conjugates including 2-3SLe
x -CMPul at least reach the marginal zone of the spleen and may act as an adjuvant. Unfortunately, we could not confirm whether the marginal zone macrophages or the marginal metallophilic macrophages ingested CMPul conjugates. To identify the cells that takes up CMPul conjugates, 28) we are now trying to combine microautoradiography with immunohistochemical analyses using the monoclonal antibodies recognizing the macrophage-related antigens (ED1, ED2, ED3).
Here, we have suggested that CMPul conjugates, in particular 2-3SLe
x -CMPul, may be promising as a novel drug delivery carrier to target drugs to the spleen and the lymph nodes and offer the potential for application to the treatment of autoimmune diseases, AIDS, Hodgkin's disease and many kinds of lymphoma, for vaccination, and for the imaging of the spleen and the lymph nodes. We are now studying the therapeutic effect of drug-carrying CMPul or CMPul conjugates in animal models.
